Navigation Links
Scripps Research cancer biology department awarded more than $8 million in new research grants
Date:4/22/2009

"The fact that our scientists have been so successful in winning these awards speaks volumes for the high caliber of research being performed at Scripps Florida and in the Department of Cancer Biology," said John Cleveland, Ph.D., chairman of the department, which is located on the Jupiter, Florida campus of TSRI. "During these times when funding is so tight, to have so many of our investigators be given awards is remarkable."

The grants, from the NIH and the Department of Defense, included the following awards:

  • Howard Petrie, Ph.D., received a pair of grants from the NIH worth a total of $4.3 million dollars over the next five years.

    Petrie's first grant (approximately $2.4 million) studies how a gene known as Notch3 that controls the development and production of T lymphocytes, white blood cells whose development starts in the bone marrow but is completed in the thymus, and then attack infectious agents as well as cancer cells. Petrie and his colleagues have discovered that inactivation of Notch3 results in an accelerated, age-related decline in the ability of the bone marrow to replenish T lymphocytes; Notch3 has also been implicated in another age-related degenerative disorder, relating to stroke. Petrie's goal is to understand how Notch3 normally prevents this aging of the immune system, and how Notch3 functions in general in blood cells as well as other tissue types.

The second grant (approximately $1.9 million) will support Petrie's work understanding regrowth of the thymus in adults and the elderly. Decreases in T cell immunity are a direct consequence of age-related degeneration of the thymus, a process that has been linked to premature aging of stromal cells (which form the supportive framework of the thymus and other organs). Using an experimental model of thymus regrowth, Dr. Petrie and his colleagues will seek to identify the changes in gene expression that occur after induction of regrowth, and to
'/>"/>

Contact: Keith McKeown
kmckeown@scripps.edu
858-784-8134
Scripps Research Institute
Source:Eurekalert

Page: 1 2

Related medicine news :

1. Scripps research scientists model 3D structures of proteins that control human clock
2. Scripps Health Selects Allscripts for Electronic Health Record
3. Scripps research scientists engineer new type of vaccination that provides instant immunity
4. Scripps research scientists develop general-purpose method for detecting trace chemicals
5. Team led by Scripps Scientists increases understanding of two types of blindness
6. KRAUSE, KALFAYAN, BENINK & SLAVENS, LLP, Announces Filing a Class Action Lawsuit Against Scripps Health, et al.
7. Scripps Health Enhances Employee Wellness Program With Home Testing Solutions From BioIQ
8. Scripps Research Institute and IAVI launch worlds first dedicated HIV neutralizing antibody center
9. Scripps Translational Science Institute Contributes to Discovery of Predisposition Gene for Childhood Cancer
10. Scripps research team unravels new cellular repair mechanism
11. Scripps Research scientists find seizure drug reverses cellular effects
Post Your Comments:
*Name:
*Comment:
*Email:
Breaking Medicine News(10 mins):Health News:AUL Action Challenges Planned Parenthood to Reveal Financial Interest in Health Care Legislation 2Health News:New York Women's Agenda Presents AUA Foundation Executive Director Sandra Vassos with Star Award 2Health News:New York Women's Agenda Presents AUA Foundation Executive Director Sandra Vassos with Star Award 3Health News:**In Case You Missed It** Louisiana Small Business Owners Need Health Care Reform 2Health News:**In Case You Missed It** Louisiana Small Business Owners Need Health Care Reform 3Health News:**In Case You Missed It** Louisiana Small Business Owners Need Health Care Reform 4Health News:Leading Orthopaedic Surgeon Thomas A. Einhorn Offers Breakthrough Non-Embryonic Stem Cell Surgery to Reverse Early Necrosis of the Hip 2Health News:Leading Orthopaedic Surgeon Thomas A. Einhorn Offers Breakthrough Non-Embryonic Stem Cell Surgery to Reverse Early Necrosis of the Hip 3Health News:Leading Orthopaedic Surgeon Thomas A. Einhorn Offers Breakthrough Non-Embryonic Stem Cell Surgery to Reverse Early Necrosis of the Hip 4Health News:Emergency Medical Associates (EMA) Launches Comprehensive Wellness Program with EngagementHealth(R) 2
Other Medicine News:Health News:Bio-imaging mass spectrometry techniques reveal molecular details about complex systems 2Health News:Bio-imaging mass spectrometry techniques reveal molecular details about complex systems 3Health News:Bio-imaging mass spectrometry techniques reveal molecular details about complex systems 4Health News: Brain Aneurysm Rupture Risk Tied to Location, Size 2Health News:Longs Drug Announces Immunization Program for the 2008/2009 Flu Season 2Health News:Longs Drug Announces Immunization Program for the 2008/2009 Flu Season 3Health News:Longs Drug Announces Immunization Program for the 2008/2009 Flu Season 4Health News:Message to Tennessee Residents: Forgo Fad Dieting and Join the Campaign for Healthy Weight 2Health News:Message to Tennessee Residents: Forgo Fad Dieting and Join the Campaign for Healthy Weight 3Health News:Video: One A Day(R) and Ellen DeGeneres Team Up to Deliver a Message to Women About Breast Cancer Through The 'One A Day Women's Wake-Up Call' Program 2Health News:Video: One A Day(R) and Ellen DeGeneres Team Up to Deliver a Message to Women About Breast Cancer Through The 'One A Day Women's Wake-Up Call' Program 3
Breaking Medicine Technology:AMP Receives $1.4 Million Grant From the Bill & Melinda Gates Foundation to Improve Advocacy for VACCINES and Immunization Systems in West Africa 2AMP Receives $1.4 Million Grant From the Bill & Melinda Gates Foundation to Improve Advocacy for VACCINES and Immunization Systems in West Africa 3Seven New Biopharmaceutical Research Companies Join PhRMA's Mission to Advance Medical Innovation 2Seven New Biopharmaceutical Research Companies Join PhRMA's Mission to Advance Medical Innovation 3Seven New Biopharmaceutical Research Companies Join PhRMA's Mission to Advance Medical Innovation 4ARKRAY, Inc. Announces Partnership With scil animal care company for the SPOTCHEM(TM) EZ Analyzer 2Aethlon Medical Releases Shareholder Letter 57187 1Aethlon Medical Releases Shareholder Letter 57187 2Aethlon Medical Releases Shareholder Letter 57187 3Childrens Author Tells Americas Youth To Dream Big By Inspiring The Hero In Every Child 57182 1Childrens Author Tells Americas Youth To Dream Big By Inspiring The Hero In Every Child 57182 2Childrens Author Tells Americas Youth To Dream Big By Inspiring The Hero In Every Child 57182 3Poniard Pharmaceuticals Announces Pivotal Phase 3 SPEAR Trial Evaluating Picoplatin in Small Cell Lung Cancer Reaches 320th Event Target 14054 1Poniard Pharmaceuticals Announces Pivotal Phase 3 SPEAR Trial Evaluating Picoplatin in Small Cell Lung Cancer Reaches 320th Event Target 14054 2Poniard Pharmaceuticals Announces Pivotal Phase 3 SPEAR Trial Evaluating Picoplatin in Small Cell Lung Cancer Reaches 320th Event Target 14054 3Poniard Pharmaceuticals Announces Pivotal Phase 3 SPEAR Trial Evaluating Picoplatin in Small Cell Lung Cancer Reaches 320th Event Target 14054 4Poniard Pharmaceuticals Announces Pivotal Phase 3 SPEAR Trial Evaluating Picoplatin in Small Cell Lung Cancer Reaches 320th Event Target 14054 5